Ключові слова
Європейський Клуб Панкреатологів, Український Клуб Панкреатологів, діагностика та лікування хронічного панкреатиту, панкреатична недостатність, Креон
Як цитувати
Gubergrits, N. B., Byelyayeva, N. V., Lukashevich, G. M., Klochkov, A. Y., Fomenko, P. G., Yaroshenko, L. A., Yuryeva, A. V., & Rakhmetova, V. S. (2018). Новини Європейської панкреатології (за матеріалами 50-ї зустрічі Європейського Клубу Панкреатологів). Вісник клубу панкреатологів, 41(4), 4-15. https://doi.org/10.33149/vkp.2018.04.01
Переглядів анотації: 723 Завантажень PDF: 385 Завантажень PDF: 175
Анотація
У статті викладені результати основних наукових досліджень в галузі панкреатології, які були проведені в 2016–2017 роках. Представлено досягнення провідних панкреатологів Європи у вивченні етіології, патогенезу, діагностики, лікування панкреатитів, пухлин підшлункової залози.
Посилання
1. 50th European Pancreatic Club (EPC) meeting // Pancreatology. – 2018. – Vol. 18, No 4S. – P. S1–S188.
2. Cardiovascular risk (CVR) associated with pancreatic exocrine insufficiency (PEI) in patients with chronic pancreatitis (CP) / N. Vallejo-Senra, D. De la Inglesia-Garcia, A. Lopez-Lopez [et al.] / 48th European Pancreatic Club (EPC) meeting // Pancreatology. – 2016. – Vol. 16, No 3S1. – P. S80.
3. Chylomicronemia risk factors ranked by importance for the individual and community in 108 711 women and men / S. B. Pedersen, A. Varbo, A. Langsted, B. G. Nordestgaard // J. Intern. Med. – 2018. – Vol. 283, No 4. – P. 392–404.
4. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis / J. E. Dominguez-Munoz, J. Iglesias-Garcia, M. Vilarino-Insua, M. Iglesias-Rey // Clin. Gastroenterol. Hepatol. – 2007. – Vol. 5, No 4. – P. 484–488.
5. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency : a randomized, three-way crossover study / J. E. Dominguez-Munoz, J. Iglesias-Garcia, M. Iglesias-Rey [et al.] // Aliment. Pharmacol. Ther. – 2005. – Vol. 21, No 8. – P. 993–1000.
6. English language version of the S3-consensus guidelines on chronic pancreatitis: definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis / A. Hoffmeister, J. Mayerle, C. Beglinger [et al.] // Z. Gastroenterol. – 2015. – Vol. 53, No 12. – P. 1447–1495.
7. Ewald N. Severe hypertriglyceridemia and pancreatitis: presentation and management / N. Ewald, P. D. Hardt, H. U. Kloer / Curr. Opin. Lipidol. – 2009. – Vol. 20, No 6. – P. 497–504.
8. Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment / L. Frulloni, C. Scattolini, A. M. Katsotourchi [et al.] // Pancreatology. – 2010. – Vol. 10, No 2–3. – P. 129–133.
9. Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection / L. Benini, A. Amodio, P. Campagnola [et al.] // Pancreatology. – 2013. – Vol. 13, No 1. – P. 38–42.
10. High prevalence of low-trauma fracture in chronic pancreatitis / A. S. Tignor, B. U. Wu, T. L. Whitlock [et al.] // Am. J. Gastroenterol. – 2010. – Vol. 105, No 12. – P. 2680–2686.
11. IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations / P. A. Viachou, K. Khalili, H. J. Jang [et al.] // Radiographics. – 2011. – Vol. 31, No 5. – P. 1379–1402.
12. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis / D. de la Iglesia, N. Vallejo-Senra, J. Iglesias-Garcia [et al.] // J. Clin. Gastroenterol. – 2017. – Epub ahead of print.
13. Italian consensus guidelines for chronic pancreatitis / L. Frulloni, M. Falconi, A. Gabbrielli [et al.] // Dig. Liver Dis. – 2010. – Vol. 42, Suppl. 6. – P. S381–406.
14. Long-term outcomes of autoimmune pancreatitis : a multicentre, international analysis / P. A. Hart, T. Kamisawa, W. R. Brugge [et al.] // Gut. – 2013. – Vol. 62, No 12. – P. 1771–1776.
15. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts / J. E. Dominguez-Munoz, J. Iglesias-Garcia, M. Iglesias-Rey, M. Vilarino-Insua // Gut. – 2006. – Vol. 55, No 7. – P. 1056–1057.
16. Prevalence and incidence of autoimmune pancreatitis in the population living in the southwest of Germany / A. Schneider, H. Michaely, C. Weiss [et al.] // Digestion. – 2017. – Vol. 96, No 4. – P. 187–198.
17. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI) / H. M. Ni Chonchubhair, Y. Bashir, M. Dobson [et al.] // Pancreatology. – 2018. – Vol. 18, No 4. – P. 379–385.
18. A prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor / E. C. Sikkens, D. L. Cahen, J. de Wit [et al.] // J. Clin. Gastroenterol. – 2014. – Vol. 48, No 5. – P. e43–46.
19. Recommendations of the Spanish Pancreatic Club on the diagnosis and treatment of chronic pancreatitis: Part 2 (treatment) / E. de-Madaria, A. Abad-Gonzalez, J. R. Aparicio [et al.] // Gastroenterol. Hepatol. – 2013. – Vol. 36, No 6. – P. 422–436.
20. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease / R. Shintakuya, K. Uemura, Y. Murakami [et al.] // Pancreatology. – 2017. – Vol. 17, No 1. – P. 70–75.
21. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) / J. M. Lohr, E. Dominguez-Munoz, J. Rosendahl [et al.] // UEG Journal. – 2017. – Vol. 5, No 2. – P. 1–47.
2. Cardiovascular risk (CVR) associated with pancreatic exocrine insufficiency (PEI) in patients with chronic pancreatitis (CP) / N. Vallejo-Senra, D. De la Inglesia-Garcia, A. Lopez-Lopez [et al.] / 48th European Pancreatic Club (EPC) meeting // Pancreatology. – 2016. – Vol. 16, No 3S1. – P. S80.
3. Chylomicronemia risk factors ranked by importance for the individual and community in 108 711 women and men / S. B. Pedersen, A. Varbo, A. Langsted, B. G. Nordestgaard // J. Intern. Med. – 2018. – Vol. 283, No 4. – P. 392–404.
4. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis / J. E. Dominguez-Munoz, J. Iglesias-Garcia, M. Vilarino-Insua, M. Iglesias-Rey // Clin. Gastroenterol. Hepatol. – 2007. – Vol. 5, No 4. – P. 484–488.
5. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency : a randomized, three-way crossover study / J. E. Dominguez-Munoz, J. Iglesias-Garcia, M. Iglesias-Rey [et al.] // Aliment. Pharmacol. Ther. – 2005. – Vol. 21, No 8. – P. 993–1000.
6. English language version of the S3-consensus guidelines on chronic pancreatitis: definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis / A. Hoffmeister, J. Mayerle, C. Beglinger [et al.] // Z. Gastroenterol. – 2015. – Vol. 53, No 12. – P. 1447–1495.
7. Ewald N. Severe hypertriglyceridemia and pancreatitis: presentation and management / N. Ewald, P. D. Hardt, H. U. Kloer / Curr. Opin. Lipidol. – 2009. – Vol. 20, No 6. – P. 497–504.
8. Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment / L. Frulloni, C. Scattolini, A. M. Katsotourchi [et al.] // Pancreatology. – 2010. – Vol. 10, No 2–3. – P. 129–133.
9. Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection / L. Benini, A. Amodio, P. Campagnola [et al.] // Pancreatology. – 2013. – Vol. 13, No 1. – P. 38–42.
10. High prevalence of low-trauma fracture in chronic pancreatitis / A. S. Tignor, B. U. Wu, T. L. Whitlock [et al.] // Am. J. Gastroenterol. – 2010. – Vol. 105, No 12. – P. 2680–2686.
11. IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations / P. A. Viachou, K. Khalili, H. J. Jang [et al.] // Radiographics. – 2011. – Vol. 31, No 5. – P. 1379–1402.
12. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis / D. de la Iglesia, N. Vallejo-Senra, J. Iglesias-Garcia [et al.] // J. Clin. Gastroenterol. – 2017. – Epub ahead of print.
13. Italian consensus guidelines for chronic pancreatitis / L. Frulloni, M. Falconi, A. Gabbrielli [et al.] // Dig. Liver Dis. – 2010. – Vol. 42, Suppl. 6. – P. S381–406.
14. Long-term outcomes of autoimmune pancreatitis : a multicentre, international analysis / P. A. Hart, T. Kamisawa, W. R. Brugge [et al.] // Gut. – 2013. – Vol. 62, No 12. – P. 1771–1776.
15. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts / J. E. Dominguez-Munoz, J. Iglesias-Garcia, M. Iglesias-Rey, M. Vilarino-Insua // Gut. – 2006. – Vol. 55, No 7. – P. 1056–1057.
16. Prevalence and incidence of autoimmune pancreatitis in the population living in the southwest of Germany / A. Schneider, H. Michaely, C. Weiss [et al.] // Digestion. – 2017. – Vol. 96, No 4. – P. 187–198.
17. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI) / H. M. Ni Chonchubhair, Y. Bashir, M. Dobson [et al.] // Pancreatology. – 2018. – Vol. 18, No 4. – P. 379–385.
18. A prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor / E. C. Sikkens, D. L. Cahen, J. de Wit [et al.] // J. Clin. Gastroenterol. – 2014. – Vol. 48, No 5. – P. e43–46.
19. Recommendations of the Spanish Pancreatic Club on the diagnosis and treatment of chronic pancreatitis: Part 2 (treatment) / E. de-Madaria, A. Abad-Gonzalez, J. R. Aparicio [et al.] // Gastroenterol. Hepatol. – 2013. – Vol. 36, No 6. – P. 422–436.
20. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease / R. Shintakuya, K. Uemura, Y. Murakami [et al.] // Pancreatology. – 2017. – Vol. 17, No 1. – P. 70–75.
21. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) / J. M. Lohr, E. Dominguez-Munoz, J. Rosendahl [et al.] // UEG Journal. – 2017. – Vol. 5, No 2. – P. 1–47.